Review



ythdf1 antibody  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    MedChemExpress ythdf1 antibody
    Erianin targets <t>YTHDF1</t> directly. A Synthesis of erianin-biotin. B Erianin-biotin 1H NMR spectrum. C CCK-8 results for Ishikawa and HEC-1-B cells incubated with erianin-biotin and erianin (50 and 100 nM) for 24 h. D Schematic workflow of protein array screening to identify erianin targets. E Representative images of the human proteomics chip. Blue, red, and yellow: negative control, positive control, and positive spot, respectively. F Molecular docking simulation of the binding between erianin and YTHDF1. G Thermal stability of erianin and YTHDF1 in EC cells detected using CESTA. H Quantification of YTHDF1 expression. I Expression of YTHDF1 in normal endometrium and EC tissues determined from the CPTAC proteomic database. J Immunohistochemistry (IHC) staining of YTHDF1 in normal endometrium and EC tissues. Scale bar = 20 μm. (K-N) EC cells were incubated with erianin (100 nM). K qRT‒PCR analysis of YTHDF1 expression. L Western blots of YTHDF1 expression. M Ishikawa cells were treated with erianin (100 nM) and cycloheximide (CHX) (50 mg/mL). N Ishikawa cells were treated with MG132 or CQ. O Ubiquitination assay of YTHDF1in the lysates from Erianin treated- EC cells in the presence of MG132 (20 μM). The data are shown as the means ± SD; n = 3; ***P < 0.001 compared with the NC (control group). ns, not significant
    Ythdf1 Antibody, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ythdf1/YTHDF1+Antibody/pmc13054981-133-5-20
    Average 94 stars, based on 1 article reviews
    ythdf1 antibody - by Bioz Stars, 2026-10
    94/100 stars

    Images

    1) Product Images from "Erianin facilitates pyroptosis in endometrial cancer via targeting m6A reader YTHDF1"

    Article Title: Erianin facilitates pyroptosis in endometrial cancer via targeting m6A reader YTHDF1

    Journal: Chinese Medicine

    doi: 10.1186/s13020-025-01313-9

    Erianin targets YTHDF1 directly. A Synthesis of erianin-biotin. B Erianin-biotin 1H NMR spectrum. C CCK-8 results for Ishikawa and HEC-1-B cells incubated with erianin-biotin and erianin (50 and 100 nM) for 24 h. D Schematic workflow of protein array screening to identify erianin targets. E Representative images of the human proteomics chip. Blue, red, and yellow: negative control, positive control, and positive spot, respectively. F Molecular docking simulation of the binding between erianin and YTHDF1. G Thermal stability of erianin and YTHDF1 in EC cells detected using CESTA. H Quantification of YTHDF1 expression. I Expression of YTHDF1 in normal endometrium and EC tissues determined from the CPTAC proteomic database. J Immunohistochemistry (IHC) staining of YTHDF1 in normal endometrium and EC tissues. Scale bar = 20 μm. (K-N) EC cells were incubated with erianin (100 nM). K qRT‒PCR analysis of YTHDF1 expression. L Western blots of YTHDF1 expression. M Ishikawa cells were treated with erianin (100 nM) and cycloheximide (CHX) (50 mg/mL). N Ishikawa cells were treated with MG132 or CQ. O Ubiquitination assay of YTHDF1in the lysates from Erianin treated- EC cells in the presence of MG132 (20 μM). The data are shown as the means ± SD; n = 3; ***P < 0.001 compared with the NC (control group). ns, not significant
    Figure Legend Snippet: Erianin targets YTHDF1 directly. A Synthesis of erianin-biotin. B Erianin-biotin 1H NMR spectrum. C CCK-8 results for Ishikawa and HEC-1-B cells incubated with erianin-biotin and erianin (50 and 100 nM) for 24 h. D Schematic workflow of protein array screening to identify erianin targets. E Representative images of the human proteomics chip. Blue, red, and yellow: negative control, positive control, and positive spot, respectively. F Molecular docking simulation of the binding between erianin and YTHDF1. G Thermal stability of erianin and YTHDF1 in EC cells detected using CESTA. H Quantification of YTHDF1 expression. I Expression of YTHDF1 in normal endometrium and EC tissues determined from the CPTAC proteomic database. J Immunohistochemistry (IHC) staining of YTHDF1 in normal endometrium and EC tissues. Scale bar = 20 μm. (K-N) EC cells were incubated with erianin (100 nM). K qRT‒PCR analysis of YTHDF1 expression. L Western blots of YTHDF1 expression. M Ishikawa cells were treated with erianin (100 nM) and cycloheximide (CHX) (50 mg/mL). N Ishikawa cells were treated with MG132 or CQ. O Ubiquitination assay of YTHDF1in the lysates from Erianin treated- EC cells in the presence of MG132 (20 μM). The data are shown as the means ± SD; n = 3; ***P < 0.001 compared with the NC (control group). ns, not significant

    Techniques Used: CCK-8 Assay, Incubation, Protein Array, Negative Control, Positive Control, Binding Assay, Expressing, Immunohistochemistry, Western Blot, Ubiquitin Proteomics, Control

    Erianin-induced EC pyroptosis depends on YTHDF1. EC cells were transfected with shYTHDF1 and YTHDF1 vectors. A Survival of EC cells incubated with erianin (100 nM) for 24 h, as detected using CCK-8 assays. B LDH release assay. C , D Western blots of YTHDF1, cleaved GSDME and cleaved caspase-3 in EC cells. E Colony formation assay. F Phase-contrast microscopy images of morphological features. Scale bar, 50 μm. G Representative images of γ-H2AX staining with immunofluorescence. Scale bar, 50 μm. The data are presented as the means ± SD; n = 3, ***P < 0.001 compared with the NC (control group)
    Figure Legend Snippet: Erianin-induced EC pyroptosis depends on YTHDF1. EC cells were transfected with shYTHDF1 and YTHDF1 vectors. A Survival of EC cells incubated with erianin (100 nM) for 24 h, as detected using CCK-8 assays. B LDH release assay. C , D Western blots of YTHDF1, cleaved GSDME and cleaved caspase-3 in EC cells. E Colony formation assay. F Phase-contrast microscopy images of morphological features. Scale bar, 50 μm. G Representative images of γ-H2AX staining with immunofluorescence. Scale bar, 50 μm. The data are presented as the means ± SD; n = 3, ***P < 0.001 compared with the NC (control group)

    Techniques Used: Transfection, Incubation, CCK-8 Assay, Lactate Dehydrogenase Assay, Western Blot, Colony Assay, Microscopy, Staining, Immunofluorescence, Control

    YTHDF1 regulates FOXM1 mRNA stability in EC. A Correlation between YTHDF1 mRNA and FOXM1 mRNA using the GEPIA database. B qRT‒PCR and western blotting experiments were used to validate FOXM1 expression in EC cells transfected with shYTHDF1. C qRT‒PCR and western blotting experiments were used to validate FOXM1 expression in EC cells transfected with shYTHDF1. D , E Relative expression of FOXM1 in Ishikawa and HEC-1-B cells with silenced YTHDF1 incubated with actinomycin D (5 μg/mL). F Results of the RIP assays showing YTHDF1-FOXM1 mRNA binding in the HEC-1-B cells incubated with erianin. G Results of the RIP assays showing YTHDF1-FOXM1 mRNA binding in the HEC-1-B cells with silenced YTHDF1. The data are presented as the mean ± SD; n = 3, *P < 0.05, **P < 0.01, and ***P < 0.001 compared with the NC (control group)
    Figure Legend Snippet: YTHDF1 regulates FOXM1 mRNA stability in EC. A Correlation between YTHDF1 mRNA and FOXM1 mRNA using the GEPIA database. B qRT‒PCR and western blotting experiments were used to validate FOXM1 expression in EC cells transfected with shYTHDF1. C qRT‒PCR and western blotting experiments were used to validate FOXM1 expression in EC cells transfected with shYTHDF1. D , E Relative expression of FOXM1 in Ishikawa and HEC-1-B cells with silenced YTHDF1 incubated with actinomycin D (5 μg/mL). F Results of the RIP assays showing YTHDF1-FOXM1 mRNA binding in the HEC-1-B cells incubated with erianin. G Results of the RIP assays showing YTHDF1-FOXM1 mRNA binding in the HEC-1-B cells with silenced YTHDF1. The data are presented as the mean ± SD; n = 3, *P < 0.05, **P < 0.01, and ***P < 0.001 compared with the NC (control group)

    Techniques Used: Western Blot, Expressing, Transfection, Incubation, Binding Assay, Control

    Erianin suppresses EC tumour growth in vivo. A Scheme of the animal experiments. B Erianin inhibits subcutaneous xenograft growth. (n = 6). C Tumor growth curves showing the effects of erianin on EC tumor xenograft growth (n = 6). D Tumor weight. E The protein levels of YTHDF1, caspase-3, cleaved-caspase3, and GSDME in tumor tissues. F Immunohistochemistry (IHC) staining of YTHDF1 in xenografts. Scale bar, 50 μm. G Weight evaluation of mice under Erianin treatment. H Representative images of livers, spleens, and kidneys stained with hematoxylin and eosin (H&E) at the end of the study. Scale bar, 100 μm. I Blood sample biochemical analysis: red blood cells (RBC); white blood cells (WBC); urea (UA); creatinine (CR); aspartate aminotransferase (AST), and alanine aminotransferase (ALT). The data are presented as the means ± SD, n = 6, ***P < 0.001 compared to the NC (control group); ns, not significant
    Figure Legend Snippet: Erianin suppresses EC tumour growth in vivo. A Scheme of the animal experiments. B Erianin inhibits subcutaneous xenograft growth. (n = 6). C Tumor growth curves showing the effects of erianin on EC tumor xenograft growth (n = 6). D Tumor weight. E The protein levels of YTHDF1, caspase-3, cleaved-caspase3, and GSDME in tumor tissues. F Immunohistochemistry (IHC) staining of YTHDF1 in xenografts. Scale bar, 50 μm. G Weight evaluation of mice under Erianin treatment. H Representative images of livers, spleens, and kidneys stained with hematoxylin and eosin (H&E) at the end of the study. Scale bar, 100 μm. I Blood sample biochemical analysis: red blood cells (RBC); white blood cells (WBC); urea (UA); creatinine (CR); aspartate aminotransferase (AST), and alanine aminotransferase (ALT). The data are presented as the means ± SD, n = 6, ***P < 0.001 compared to the NC (control group); ns, not significant

    Techniques Used: In Vivo, Immunohistochemistry, Staining, Control

    Related Articles

    Transfection:

    Article Title: CD147 mediates the adsorption of influenza A virus on the cell surface through direct interaction with HA
    Article Snippet: .. The viability of DF1 and A549 cells following transfection, treatment with small molecule reagents, or knockout (KO) was assessed using a Cell-Counting Kit-8 (CCK-8) assay, according to the manufacturer’s instructions (MedChemExpress, #HY-K0301) ( ). ..

    Article Title: Elevated SPARC Disrupts the Intestinal Barrier Integrity in Crohn's Disease by Interacting with OTUD4 and Activating the MYD88/NF-κB Pathway.
    Article Snippet: .. Half-Life of SPARC Measurement: 3 × 105 Caco-2 cells were seeded in a 6-well plate and either transfected with the YTHDF1 overexpression plasmids (Miaolingbio) or treated with the METTL3 inhibitor STM2457 (10 μM, MCE, USA, #2499663-01-1) for 48 h. Subsequently, the cells were exposed to cycloheximide (CHX, 40 μM, MCE, #66-81-9) for 0, 3, 6, 9, and 12 h. At each designated time point, the cells were harvested, and total protein lysates were prepared for western blot analysis to determine the expression levels of SPARC. .. Statistical Analysis: The statistical analysis in this study was performed using GraphPad Prism (version 8.0).

    Article Title: Elevated SPARC Disrupts the Intestinal Barrier Integrity in Crohn's Disease by Interacting with OTUD4 and Activating the MYD88/NF‐κB Pathway
    Article Snippet: .. 3 × 10 5 Caco‐2 cells were seeded in a 6‐well plate and either transfected with the YTHDF1 overexpression plasmids (Miaolingbio) or treated with the METTL3 inhibitor STM2457 (10 μM, MCE, USA, #2499663‐01‐1) for 48 h. Subsequently, the cells were exposed to cycloheximide (CHX, 40 μM, MCE, #66‐81‐9) for 0, 3, 6, 9, and 12 h. At each designated time point, the cells were harvested, and total protein lysates were prepared for western blot analysis to determine the expression levels of SPARC. .. The statistical analysis in this study was performed using GraphPad Prism (version 8.0).

    Knock-Out:

    Article Title: CD147 mediates the adsorption of influenza A virus on the cell surface through direct interaction with HA
    Article Snippet: .. The viability of DF1 and A549 cells following transfection, treatment with small molecule reagents, or knockout (KO) was assessed using a Cell-Counting Kit-8 (CCK-8) assay, according to the manufacturer’s instructions (MedChemExpress, #HY-K0301) ( ). ..

    Cell Counting:

    Article Title: CD147 mediates the adsorption of influenza A virus on the cell surface through direct interaction with HA
    Article Snippet: .. The viability of DF1 and A549 cells following transfection, treatment with small molecule reagents, or knockout (KO) was assessed using a Cell-Counting Kit-8 (CCK-8) assay, according to the manufacturer’s instructions (MedChemExpress, #HY-K0301) ( ). ..

    CCK-8 Assay:

    Article Title: CD147 mediates the adsorption of influenza A virus on the cell surface through direct interaction with HA
    Article Snippet: .. The viability of DF1 and A549 cells following transfection, treatment with small molecule reagents, or knockout (KO) was assessed using a Cell-Counting Kit-8 (CCK-8) assay, according to the manufacturer’s instructions (MedChemExpress, #HY-K0301) ( ). ..

    Incubation:

    Article Title: Erianin facilitates pyroptosis in endometrial cancer via targeting m6A reader YTHDF1
    Article Snippet: For the ubiquitination analysis, EC cells were treated with 20 μM MG132 and 100 nM erianin or 20 μM MG132 for 6 h. The cells were lysed on ice using immunoprecipitation (IP) lysis buffer (P0013, Beyotime, China). .. The lysates were incubated with YTHDF1 antibody overnight at 4 °C, followed by addition of protein A/G magnetic beads (HY-K0202, MedChemExpress) and incubation for 4 h at 4 °C. ..

    Magnetic Beads:

    Article Title: Erianin facilitates pyroptosis in endometrial cancer via targeting m6A reader YTHDF1
    Article Snippet: For the ubiquitination analysis, EC cells were treated with 20 μM MG132 and 100 nM erianin or 20 μM MG132 for 6 h. The cells were lysed on ice using immunoprecipitation (IP) lysis buffer (P0013, Beyotime, China). .. The lysates were incubated with YTHDF1 antibody overnight at 4 °C, followed by addition of protein A/G magnetic beads (HY-K0202, MedChemExpress) and incubation for 4 h at 4 °C. ..

    Over Expression:

    Article Title: Elevated SPARC Disrupts the Intestinal Barrier Integrity in Crohn's Disease by Interacting with OTUD4 and Activating the MYD88/NF-κB Pathway.
    Article Snippet: .. Half-Life of SPARC Measurement: 3 × 105 Caco-2 cells were seeded in a 6-well plate and either transfected with the YTHDF1 overexpression plasmids (Miaolingbio) or treated with the METTL3 inhibitor STM2457 (10 μM, MCE, USA, #2499663-01-1) for 48 h. Subsequently, the cells were exposed to cycloheximide (CHX, 40 μM, MCE, #66-81-9) for 0, 3, 6, 9, and 12 h. At each designated time point, the cells were harvested, and total protein lysates were prepared for western blot analysis to determine the expression levels of SPARC. .. Statistical Analysis: The statistical analysis in this study was performed using GraphPad Prism (version 8.0).

    Article Title: Elevated SPARC Disrupts the Intestinal Barrier Integrity in Crohn's Disease by Interacting with OTUD4 and Activating the MYD88/NF‐κB Pathway
    Article Snippet: .. 3 × 10 5 Caco‐2 cells were seeded in a 6‐well plate and either transfected with the YTHDF1 overexpression plasmids (Miaolingbio) or treated with the METTL3 inhibitor STM2457 (10 μM, MCE, USA, #2499663‐01‐1) for 48 h. Subsequently, the cells were exposed to cycloheximide (CHX, 40 μM, MCE, #66‐81‐9) for 0, 3, 6, 9, and 12 h. At each designated time point, the cells were harvested, and total protein lysates were prepared for western blot analysis to determine the expression levels of SPARC. .. The statistical analysis in this study was performed using GraphPad Prism (version 8.0).

    Western Blot:

    Article Title: Elevated SPARC Disrupts the Intestinal Barrier Integrity in Crohn's Disease by Interacting with OTUD4 and Activating the MYD88/NF-κB Pathway.
    Article Snippet: .. Half-Life of SPARC Measurement: 3 × 105 Caco-2 cells were seeded in a 6-well plate and either transfected with the YTHDF1 overexpression plasmids (Miaolingbio) or treated with the METTL3 inhibitor STM2457 (10 μM, MCE, USA, #2499663-01-1) for 48 h. Subsequently, the cells were exposed to cycloheximide (CHX, 40 μM, MCE, #66-81-9) for 0, 3, 6, 9, and 12 h. At each designated time point, the cells were harvested, and total protein lysates were prepared for western blot analysis to determine the expression levels of SPARC. .. Statistical Analysis: The statistical analysis in this study was performed using GraphPad Prism (version 8.0).

    Article Title: Elevated SPARC Disrupts the Intestinal Barrier Integrity in Crohn's Disease by Interacting with OTUD4 and Activating the MYD88/NF‐κB Pathway
    Article Snippet: .. 3 × 10 5 Caco‐2 cells were seeded in a 6‐well plate and either transfected with the YTHDF1 overexpression plasmids (Miaolingbio) or treated with the METTL3 inhibitor STM2457 (10 μM, MCE, USA, #2499663‐01‐1) for 48 h. Subsequently, the cells were exposed to cycloheximide (CHX, 40 μM, MCE, #66‐81‐9) for 0, 3, 6, 9, and 12 h. At each designated time point, the cells were harvested, and total protein lysates were prepared for western blot analysis to determine the expression levels of SPARC. .. The statistical analysis in this study was performed using GraphPad Prism (version 8.0).

    Expressing:

    Article Title: Elevated SPARC Disrupts the Intestinal Barrier Integrity in Crohn's Disease by Interacting with OTUD4 and Activating the MYD88/NF-κB Pathway.
    Article Snippet: .. Half-Life of SPARC Measurement: 3 × 105 Caco-2 cells were seeded in a 6-well plate and either transfected with the YTHDF1 overexpression plasmids (Miaolingbio) or treated with the METTL3 inhibitor STM2457 (10 μM, MCE, USA, #2499663-01-1) for 48 h. Subsequently, the cells were exposed to cycloheximide (CHX, 40 μM, MCE, #66-81-9) for 0, 3, 6, 9, and 12 h. At each designated time point, the cells were harvested, and total protein lysates were prepared for western blot analysis to determine the expression levels of SPARC. .. Statistical Analysis: The statistical analysis in this study was performed using GraphPad Prism (version 8.0).

    Article Title: Elevated SPARC Disrupts the Intestinal Barrier Integrity in Crohn's Disease by Interacting with OTUD4 and Activating the MYD88/NF‐κB Pathway
    Article Snippet: .. 3 × 10 5 Caco‐2 cells were seeded in a 6‐well plate and either transfected with the YTHDF1 overexpression plasmids (Miaolingbio) or treated with the METTL3 inhibitor STM2457 (10 μM, MCE, USA, #2499663‐01‐1) for 48 h. Subsequently, the cells were exposed to cycloheximide (CHX, 40 μM, MCE, #66‐81‐9) for 0, 3, 6, 9, and 12 h. At each designated time point, the cells were harvested, and total protein lysates were prepared for western blot analysis to determine the expression levels of SPARC. .. The statistical analysis in this study was performed using GraphPad Prism (version 8.0).



    Similar Products

    94
    MedChemExpress ythdf1 antibody
    Erianin targets <t>YTHDF1</t> directly. A Synthesis of erianin-biotin. B Erianin-biotin 1H NMR spectrum. C CCK-8 results for Ishikawa and HEC-1-B cells incubated with erianin-biotin and erianin (50 and 100 nM) for 24 h. D Schematic workflow of protein array screening to identify erianin targets. E Representative images of the human proteomics chip. Blue, red, and yellow: negative control, positive control, and positive spot, respectively. F Molecular docking simulation of the binding between erianin and YTHDF1. G Thermal stability of erianin and YTHDF1 in EC cells detected using CESTA. H Quantification of YTHDF1 expression. I Expression of YTHDF1 in normal endometrium and EC tissues determined from the CPTAC proteomic database. J Immunohistochemistry (IHC) staining of YTHDF1 in normal endometrium and EC tissues. Scale bar = 20 μm. (K-N) EC cells were incubated with erianin (100 nM). K qRT‒PCR analysis of YTHDF1 expression. L Western blots of YTHDF1 expression. M Ishikawa cells were treated with erianin (100 nM) and cycloheximide (CHX) (50 mg/mL). N Ishikawa cells were treated with MG132 or CQ. O Ubiquitination assay of YTHDF1in the lysates from Erianin treated- EC cells in the presence of MG132 (20 μM). The data are shown as the means ± SD; n = 3; ***P < 0.001 compared with the NC (control group). ns, not significant
    Ythdf1 Antibody, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ythdf1/YTHDF1+Antibody/pmc13054981-133-5-20
    Average 94 stars, based on 1 article reviews
    ythdf1 antibody - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    96
    Proteintech rabbit anti ythdf1
    Erianin targets <t>YTHDF1</t> directly. A Synthesis of erianin-biotin. B Erianin-biotin 1H NMR spectrum. C CCK-8 results for Ishikawa and HEC-1-B cells incubated with erianin-biotin and erianin (50 and 100 nM) for 24 h. D Schematic workflow of protein array screening to identify erianin targets. E Representative images of the human proteomics chip. Blue, red, and yellow: negative control, positive control, and positive spot, respectively. F Molecular docking simulation of the binding between erianin and YTHDF1. G Thermal stability of erianin and YTHDF1 in EC cells detected using CESTA. H Quantification of YTHDF1 expression. I Expression of YTHDF1 in normal endometrium and EC tissues determined from the CPTAC proteomic database. J Immunohistochemistry (IHC) staining of YTHDF1 in normal endometrium and EC tissues. Scale bar = 20 μm. (K-N) EC cells were incubated with erianin (100 nM). K qRT‒PCR analysis of YTHDF1 expression. L Western blots of YTHDF1 expression. M Ishikawa cells were treated with erianin (100 nM) and cycloheximide (CHX) (50 mg/mL). N Ishikawa cells were treated with MG132 or CQ. O Ubiquitination assay of YTHDF1in the lysates from Erianin treated- EC cells in the presence of MG132 (20 μM). The data are shown as the means ± SD; n = 3; ***P < 0.001 compared with the NC (control group). ns, not significant
    Rabbit Anti Ythdf1, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ythdf1/YTHDF1+Antibody/pm42533115-85-71-75
    Average 96 stars, based on 1 article reviews
    rabbit anti ythdf1 - by Bioz Stars, 2026-10
    96/100 stars
      Buy from Supplier

    94
    Proteintech ythdf1
    Erianin targets <t>YTHDF1</t> directly. A Synthesis of erianin-biotin. B Erianin-biotin 1H NMR spectrum. C CCK-8 results for Ishikawa and HEC-1-B cells incubated with erianin-biotin and erianin (50 and 100 nM) for 24 h. D Schematic workflow of protein array screening to identify erianin targets. E Representative images of the human proteomics chip. Blue, red, and yellow: negative control, positive control, and positive spot, respectively. F Molecular docking simulation of the binding between erianin and YTHDF1. G Thermal stability of erianin and YTHDF1 in EC cells detected using CESTA. H Quantification of YTHDF1 expression. I Expression of YTHDF1 in normal endometrium and EC tissues determined from the CPTAC proteomic database. J Immunohistochemistry (IHC) staining of YTHDF1 in normal endometrium and EC tissues. Scale bar = 20 μm. (K-N) EC cells were incubated with erianin (100 nM). K qRT‒PCR analysis of YTHDF1 expression. L Western blots of YTHDF1 expression. M Ishikawa cells were treated with erianin (100 nM) and cycloheximide (CHX) (50 mg/mL). N Ishikawa cells were treated with MG132 or CQ. O Ubiquitination assay of YTHDF1in the lysates from Erianin treated- EC cells in the presence of MG132 (20 μM). The data are shown as the means ± SD; n = 3; ***P < 0.001 compared with the NC (control group). ns, not significant
    Ythdf1, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ythdf1/TXNDC5+Antibody/10__1038_slash_s41598___026___68251___w-218-67-69
    Average 94 stars, based on 1 article reviews
    ythdf1 - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    94
    ABclonal Biotechnology ythdf1
    Erianin targets <t>YTHDF1</t> directly. A Synthesis of erianin-biotin. B Erianin-biotin 1H NMR spectrum. C CCK-8 results for Ishikawa and HEC-1-B cells incubated with erianin-biotin and erianin (50 and 100 nM) for 24 h. D Schematic workflow of protein array screening to identify erianin targets. E Representative images of the human proteomics chip. Blue, red, and yellow: negative control, positive control, and positive spot, respectively. F Molecular docking simulation of the binding between erianin and YTHDF1. G Thermal stability of erianin and YTHDF1 in EC cells detected using CESTA. H Quantification of YTHDF1 expression. I Expression of YTHDF1 in normal endometrium and EC tissues determined from the CPTAC proteomic database. J Immunohistochemistry (IHC) staining of YTHDF1 in normal endometrium and EC tissues. Scale bar = 20 μm. (K-N) EC cells were incubated with erianin (100 nM). K qRT‒PCR analysis of YTHDF1 expression. L Western blots of YTHDF1 expression. M Ishikawa cells were treated with erianin (100 nM) and cycloheximide (CHX) (50 mg/mL). N Ishikawa cells were treated with MG132 or CQ. O Ubiquitination assay of YTHDF1in the lysates from Erianin treated- EC cells in the presence of MG132 (20 μM). The data are shown as the means ± SD; n = 3; ***P < 0.001 compared with the NC (control group). ns, not significant
    Ythdf1, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ythdf1/YTHDF1+Rabbit+pAb/10__1186_slash_s13062___026___00939___5-52-74-75
    Average 94 stars, based on 1 article reviews
    ythdf1 - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    86
    Obio Technology Corp Ltd lentivirus carrying rat ythdf1
    Erianin targets <t>YTHDF1</t> directly. A Synthesis of erianin-biotin. B Erianin-biotin 1H NMR spectrum. C CCK-8 results for Ishikawa and HEC-1-B cells incubated with erianin-biotin and erianin (50 and 100 nM) for 24 h. D Schematic workflow of protein array screening to identify erianin targets. E Representative images of the human proteomics chip. Blue, red, and yellow: negative control, positive control, and positive spot, respectively. F Molecular docking simulation of the binding between erianin and YTHDF1. G Thermal stability of erianin and YTHDF1 in EC cells detected using CESTA. H Quantification of YTHDF1 expression. I Expression of YTHDF1 in normal endometrium and EC tissues determined from the CPTAC proteomic database. J Immunohistochemistry (IHC) staining of YTHDF1 in normal endometrium and EC tissues. Scale bar = 20 μm. (K-N) EC cells were incubated with erianin (100 nM). K qRT‒PCR analysis of YTHDF1 expression. L Western blots of YTHDF1 expression. M Ishikawa cells were treated with erianin (100 nM) and cycloheximide (CHX) (50 mg/mL). N Ishikawa cells were treated with MG132 or CQ. O Ubiquitination assay of YTHDF1in the lysates from Erianin treated- EC cells in the presence of MG132 (20 μM). The data are shown as the means ± SD; n = 3; ***P < 0.001 compared with the NC (control group). ns, not significant
    Lentivirus Carrying Rat Ythdf1, supplied by Obio Technology Corp Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ythdf1/lentivirus+overexpressing+thbs1/pmc13178915-45-12-18
    Average 86 stars, based on 1 article reviews
    lentivirus carrying rat ythdf1 - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    94
    ABclonal Biotechnology rabbit anti ythdf1
    Erianin targets <t>YTHDF1</t> directly. A Synthesis of erianin-biotin. B Erianin-biotin 1H NMR spectrum. C CCK-8 results for Ishikawa and HEC-1-B cells incubated with erianin-biotin and erianin (50 and 100 nM) for 24 h. D Schematic workflow of protein array screening to identify erianin targets. E Representative images of the human proteomics chip. Blue, red, and yellow: negative control, positive control, and positive spot, respectively. F Molecular docking simulation of the binding between erianin and YTHDF1. G Thermal stability of erianin and YTHDF1 in EC cells detected using CESTA. H Quantification of YTHDF1 expression. I Expression of YTHDF1 in normal endometrium and EC tissues determined from the CPTAC proteomic database. J Immunohistochemistry (IHC) staining of YTHDF1 in normal endometrium and EC tissues. Scale bar = 20 μm. (K-N) EC cells were incubated with erianin (100 nM). K qRT‒PCR analysis of YTHDF1 expression. L Western blots of YTHDF1 expression. M Ishikawa cells were treated with erianin (100 nM) and cycloheximide (CHX) (50 mg/mL). N Ishikawa cells were treated with MG132 or CQ. O Ubiquitination assay of YTHDF1in the lysates from Erianin treated- EC cells in the presence of MG132 (20 μM). The data are shown as the means ± SD; n = 3; ***P < 0.001 compared with the NC (control group). ns, not significant
    Rabbit Anti Ythdf1, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ythdf1/YTHDF1+Rabbit+pAb/pm41825439-840-233-238
    Average 94 stars, based on 1 article reviews
    rabbit anti ythdf1 - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    94
    Thermo Fisher gene exp ythdf1 hs00697331 m1
    Erianin targets <t>YTHDF1</t> directly. A Synthesis of erianin-biotin. B Erianin-biotin 1H NMR spectrum. C CCK-8 results for Ishikawa and HEC-1-B cells incubated with erianin-biotin and erianin (50 and 100 nM) for 24 h. D Schematic workflow of protein array screening to identify erianin targets. E Representative images of the human proteomics chip. Blue, red, and yellow: negative control, positive control, and positive spot, respectively. F Molecular docking simulation of the binding between erianin and YTHDF1. G Thermal stability of erianin and YTHDF1 in EC cells detected using CESTA. H Quantification of YTHDF1 expression. I Expression of YTHDF1 in normal endometrium and EC tissues determined from the CPTAC proteomic database. J Immunohistochemistry (IHC) staining of YTHDF1 in normal endometrium and EC tissues. Scale bar = 20 μm. (K-N) EC cells were incubated with erianin (100 nM). K qRT‒PCR analysis of YTHDF1 expression. L Western blots of YTHDF1 expression. M Ishikawa cells were treated with erianin (100 nM) and cycloheximide (CHX) (50 mg/mL). N Ishikawa cells were treated with MG132 or CQ. O Ubiquitination assay of YTHDF1in the lysates from Erianin treated- EC cells in the presence of MG132 (20 μM). The data are shown as the means ± SD; n = 3; ***P < 0.001 compared with the NC (control group). ns, not significant
    Gene Exp Ythdf1 Hs00697331 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ythdf1/Gene+Exp%2E+YTHDF1%2C+Hs00697331_m1/pm41965674-132-15-24
    Average 94 stars, based on 1 article reviews
    gene exp ythdf1 hs00697331 m1 - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    94
    Thermo Fisher gene exp ythdf1 rh02873387 m1
    Erianin targets <t>YTHDF1</t> directly. A Synthesis of erianin-biotin. B Erianin-biotin 1H NMR spectrum. C CCK-8 results for Ishikawa and HEC-1-B cells incubated with erianin-biotin and erianin (50 and 100 nM) for 24 h. D Schematic workflow of protein array screening to identify erianin targets. E Representative images of the human proteomics chip. Blue, red, and yellow: negative control, positive control, and positive spot, respectively. F Molecular docking simulation of the binding between erianin and YTHDF1. G Thermal stability of erianin and YTHDF1 in EC cells detected using CESTA. H Quantification of YTHDF1 expression. I Expression of YTHDF1 in normal endometrium and EC tissues determined from the CPTAC proteomic database. J Immunohistochemistry (IHC) staining of YTHDF1 in normal endometrium and EC tissues. Scale bar = 20 μm. (K-N) EC cells were incubated with erianin (100 nM). K qRT‒PCR analysis of YTHDF1 expression. L Western blots of YTHDF1 expression. M Ishikawa cells were treated with erianin (100 nM) and cycloheximide (CHX) (50 mg/mL). N Ishikawa cells were treated with MG132 or CQ. O Ubiquitination assay of YTHDF1in the lysates from Erianin treated- EC cells in the presence of MG132 (20 μM). The data are shown as the means ± SD; n = 3; ***P < 0.001 compared with the NC (control group). ns, not significant
    Gene Exp Ythdf1 Rh02873387 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ythdf1/Gene+Exp%2E+YTHDF1%2C+Rh02873387_m1/pm41965674-131-18--1
    Average 94 stars, based on 1 article reviews
    gene exp ythdf1 rh02873387 m1 - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    90
    Fortis Life Sciences ythdf1 rabbit
    Erianin targets <t>YTHDF1</t> directly. A Synthesis of erianin-biotin. B Erianin-biotin 1H NMR spectrum. C CCK-8 results for Ishikawa and HEC-1-B cells incubated with erianin-biotin and erianin (50 and 100 nM) for 24 h. D Schematic workflow of protein array screening to identify erianin targets. E Representative images of the human proteomics chip. Blue, red, and yellow: negative control, positive control, and positive spot, respectively. F Molecular docking simulation of the binding between erianin and YTHDF1. G Thermal stability of erianin and YTHDF1 in EC cells detected using CESTA. H Quantification of YTHDF1 expression. I Expression of YTHDF1 in normal endometrium and EC tissues determined from the CPTAC proteomic database. J Immunohistochemistry (IHC) staining of YTHDF1 in normal endometrium and EC tissues. Scale bar = 20 μm. (K-N) EC cells were incubated with erianin (100 nM). K qRT‒PCR analysis of YTHDF1 expression. L Western blots of YTHDF1 expression. M Ishikawa cells were treated with erianin (100 nM) and cycloheximide (CHX) (50 mg/mL). N Ishikawa cells were treated with MG132 or CQ. O Ubiquitination assay of YTHDF1in the lysates from Erianin treated- EC cells in the presence of MG132 (20 μM). The data are shown as the means ± SD; n = 3; ***P < 0.001 compared with the NC (control group). ns, not significant
    Ythdf1 Rabbit, supplied by Fortis Life Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ythdf1/YTHDF1+Antibody/pmc12009005-919-0-3
    Average 90 stars, based on 1 article reviews
    ythdf1 rabbit - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    Image Search Results


    Erianin targets YTHDF1 directly. A Synthesis of erianin-biotin. B Erianin-biotin 1H NMR spectrum. C CCK-8 results for Ishikawa and HEC-1-B cells incubated with erianin-biotin and erianin (50 and 100 nM) for 24 h. D Schematic workflow of protein array screening to identify erianin targets. E Representative images of the human proteomics chip. Blue, red, and yellow: negative control, positive control, and positive spot, respectively. F Molecular docking simulation of the binding between erianin and YTHDF1. G Thermal stability of erianin and YTHDF1 in EC cells detected using CESTA. H Quantification of YTHDF1 expression. I Expression of YTHDF1 in normal endometrium and EC tissues determined from the CPTAC proteomic database. J Immunohistochemistry (IHC) staining of YTHDF1 in normal endometrium and EC tissues. Scale bar = 20 μm. (K-N) EC cells were incubated with erianin (100 nM). K qRT‒PCR analysis of YTHDF1 expression. L Western blots of YTHDF1 expression. M Ishikawa cells were treated with erianin (100 nM) and cycloheximide (CHX) (50 mg/mL). N Ishikawa cells were treated with MG132 or CQ. O Ubiquitination assay of YTHDF1in the lysates from Erianin treated- EC cells in the presence of MG132 (20 μM). The data are shown as the means ± SD; n = 3; ***P < 0.001 compared with the NC (control group). ns, not significant

    Journal: Chinese Medicine

    Article Title: Erianin facilitates pyroptosis in endometrial cancer via targeting m6A reader YTHDF1

    doi: 10.1186/s13020-025-01313-9

    Figure Lengend Snippet: Erianin targets YTHDF1 directly. A Synthesis of erianin-biotin. B Erianin-biotin 1H NMR spectrum. C CCK-8 results for Ishikawa and HEC-1-B cells incubated with erianin-biotin and erianin (50 and 100 nM) for 24 h. D Schematic workflow of protein array screening to identify erianin targets. E Representative images of the human proteomics chip. Blue, red, and yellow: negative control, positive control, and positive spot, respectively. F Molecular docking simulation of the binding between erianin and YTHDF1. G Thermal stability of erianin and YTHDF1 in EC cells detected using CESTA. H Quantification of YTHDF1 expression. I Expression of YTHDF1 in normal endometrium and EC tissues determined from the CPTAC proteomic database. J Immunohistochemistry (IHC) staining of YTHDF1 in normal endometrium and EC tissues. Scale bar = 20 μm. (K-N) EC cells were incubated with erianin (100 nM). K qRT‒PCR analysis of YTHDF1 expression. L Western blots of YTHDF1 expression. M Ishikawa cells were treated with erianin (100 nM) and cycloheximide (CHX) (50 mg/mL). N Ishikawa cells were treated with MG132 or CQ. O Ubiquitination assay of YTHDF1in the lysates from Erianin treated- EC cells in the presence of MG132 (20 μM). The data are shown as the means ± SD; n = 3; ***P < 0.001 compared with the NC (control group). ns, not significant

    Article Snippet: The lysates were incubated with YTHDF1 antibody overnight at 4 °C, followed by addition of protein A/G magnetic beads (HY-K0202, MedChemExpress) and incubation for 4 h at 4 °C.

    Techniques: CCK-8 Assay, Incubation, Protein Array, Negative Control, Positive Control, Binding Assay, Expressing, Immunohistochemistry, Western Blot, Ubiquitin Proteomics, Control

    Erianin-induced EC pyroptosis depends on YTHDF1. EC cells were transfected with shYTHDF1 and YTHDF1 vectors. A Survival of EC cells incubated with erianin (100 nM) for 24 h, as detected using CCK-8 assays. B LDH release assay. C , D Western blots of YTHDF1, cleaved GSDME and cleaved caspase-3 in EC cells. E Colony formation assay. F Phase-contrast microscopy images of morphological features. Scale bar, 50 μm. G Representative images of γ-H2AX staining with immunofluorescence. Scale bar, 50 μm. The data are presented as the means ± SD; n = 3, ***P < 0.001 compared with the NC (control group)

    Journal: Chinese Medicine

    Article Title: Erianin facilitates pyroptosis in endometrial cancer via targeting m6A reader YTHDF1

    doi: 10.1186/s13020-025-01313-9

    Figure Lengend Snippet: Erianin-induced EC pyroptosis depends on YTHDF1. EC cells were transfected with shYTHDF1 and YTHDF1 vectors. A Survival of EC cells incubated with erianin (100 nM) for 24 h, as detected using CCK-8 assays. B LDH release assay. C , D Western blots of YTHDF1, cleaved GSDME and cleaved caspase-3 in EC cells. E Colony formation assay. F Phase-contrast microscopy images of morphological features. Scale bar, 50 μm. G Representative images of γ-H2AX staining with immunofluorescence. Scale bar, 50 μm. The data are presented as the means ± SD; n = 3, ***P < 0.001 compared with the NC (control group)

    Article Snippet: The lysates were incubated with YTHDF1 antibody overnight at 4 °C, followed by addition of protein A/G magnetic beads (HY-K0202, MedChemExpress) and incubation for 4 h at 4 °C.

    Techniques: Transfection, Incubation, CCK-8 Assay, Lactate Dehydrogenase Assay, Western Blot, Colony Assay, Microscopy, Staining, Immunofluorescence, Control

    YTHDF1 regulates FOXM1 mRNA stability in EC. A Correlation between YTHDF1 mRNA and FOXM1 mRNA using the GEPIA database. B qRT‒PCR and western blotting experiments were used to validate FOXM1 expression in EC cells transfected with shYTHDF1. C qRT‒PCR and western blotting experiments were used to validate FOXM1 expression in EC cells transfected with shYTHDF1. D , E Relative expression of FOXM1 in Ishikawa and HEC-1-B cells with silenced YTHDF1 incubated with actinomycin D (5 μg/mL). F Results of the RIP assays showing YTHDF1-FOXM1 mRNA binding in the HEC-1-B cells incubated with erianin. G Results of the RIP assays showing YTHDF1-FOXM1 mRNA binding in the HEC-1-B cells with silenced YTHDF1. The data are presented as the mean ± SD; n = 3, *P < 0.05, **P < 0.01, and ***P < 0.001 compared with the NC (control group)

    Journal: Chinese Medicine

    Article Title: Erianin facilitates pyroptosis in endometrial cancer via targeting m6A reader YTHDF1

    doi: 10.1186/s13020-025-01313-9

    Figure Lengend Snippet: YTHDF1 regulates FOXM1 mRNA stability in EC. A Correlation between YTHDF1 mRNA and FOXM1 mRNA using the GEPIA database. B qRT‒PCR and western blotting experiments were used to validate FOXM1 expression in EC cells transfected with shYTHDF1. C qRT‒PCR and western blotting experiments were used to validate FOXM1 expression in EC cells transfected with shYTHDF1. D , E Relative expression of FOXM1 in Ishikawa and HEC-1-B cells with silenced YTHDF1 incubated with actinomycin D (5 μg/mL). F Results of the RIP assays showing YTHDF1-FOXM1 mRNA binding in the HEC-1-B cells incubated with erianin. G Results of the RIP assays showing YTHDF1-FOXM1 mRNA binding in the HEC-1-B cells with silenced YTHDF1. The data are presented as the mean ± SD; n = 3, *P < 0.05, **P < 0.01, and ***P < 0.001 compared with the NC (control group)

    Article Snippet: The lysates were incubated with YTHDF1 antibody overnight at 4 °C, followed by addition of protein A/G magnetic beads (HY-K0202, MedChemExpress) and incubation for 4 h at 4 °C.

    Techniques: Western Blot, Expressing, Transfection, Incubation, Binding Assay, Control

    Erianin suppresses EC tumour growth in vivo. A Scheme of the animal experiments. B Erianin inhibits subcutaneous xenograft growth. (n = 6). C Tumor growth curves showing the effects of erianin on EC tumor xenograft growth (n = 6). D Tumor weight. E The protein levels of YTHDF1, caspase-3, cleaved-caspase3, and GSDME in tumor tissues. F Immunohistochemistry (IHC) staining of YTHDF1 in xenografts. Scale bar, 50 μm. G Weight evaluation of mice under Erianin treatment. H Representative images of livers, spleens, and kidneys stained with hematoxylin and eosin (H&E) at the end of the study. Scale bar, 100 μm. I Blood sample biochemical analysis: red blood cells (RBC); white blood cells (WBC); urea (UA); creatinine (CR); aspartate aminotransferase (AST), and alanine aminotransferase (ALT). The data are presented as the means ± SD, n = 6, ***P < 0.001 compared to the NC (control group); ns, not significant

    Journal: Chinese Medicine

    Article Title: Erianin facilitates pyroptosis in endometrial cancer via targeting m6A reader YTHDF1

    doi: 10.1186/s13020-025-01313-9

    Figure Lengend Snippet: Erianin suppresses EC tumour growth in vivo. A Scheme of the animal experiments. B Erianin inhibits subcutaneous xenograft growth. (n = 6). C Tumor growth curves showing the effects of erianin on EC tumor xenograft growth (n = 6). D Tumor weight. E The protein levels of YTHDF1, caspase-3, cleaved-caspase3, and GSDME in tumor tissues. F Immunohistochemistry (IHC) staining of YTHDF1 in xenografts. Scale bar, 50 μm. G Weight evaluation of mice under Erianin treatment. H Representative images of livers, spleens, and kidneys stained with hematoxylin and eosin (H&E) at the end of the study. Scale bar, 100 μm. I Blood sample biochemical analysis: red blood cells (RBC); white blood cells (WBC); urea (UA); creatinine (CR); aspartate aminotransferase (AST), and alanine aminotransferase (ALT). The data are presented as the means ± SD, n = 6, ***P < 0.001 compared to the NC (control group); ns, not significant

    Article Snippet: The lysates were incubated with YTHDF1 antibody overnight at 4 °C, followed by addition of protein A/G magnetic beads (HY-K0202, MedChemExpress) and incubation for 4 h at 4 °C.

    Techniques: In Vivo, Immunohistochemistry, Staining, Control